Display options
Share it on

Clin Drug Investig. 2021 Feb;41(2):199. doi: 10.1007/s40261-020-00999-z.

Retraction Note to: Anti-Fracture Efficacy of Risedronic Acid in Men : A Meta-Analysis of Randomized Controlled Trials.

Clinical drug investigation

Zhao-Ming Zhong, Jian-Ting Chen

Affiliations

  1. Department of Orthopedic and Spinal Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, People's Republic of China.
  2. Department of Orthopedic and Spinal Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, People's Republic of China. [email protected].

PMID: 33507528 DOI: 10.1007/s40261-020-00999-z

[No abstract available.]

References

  1. Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68:911–5. - PubMed
  2. Sato Y, Iwamoto J, Kanoko T, et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med. 2005;165:1743–8. - PubMed

Publication Types